|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hypertriglyceridemia and cardiovascular risk reduction显示文摘 | Miller M Schaefer EJ | 2007 | Clin Ther2007，29，5： | 1 |
| 2 | Chronic kidney disease and statins: improving cardiovascular outcomes 显示文摘 | Walker DB Walker TJ Jacobson TA | 2009 | Curr Ath- erosclerosis Rep2009，11，4： | 1 |
| 3 | Lipoprotein (a), cardiovascular disease, and contemporary management 显示文摘 | Jacobson TA | 2013 | Mayo Clin Proc2013，88，11： | 1 |
| 4 | Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin- intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial显示文摘 | MORIARTY PM JACOBSON TA BRUCKERT E | 2014 | J Clin Lipidol2014，8，6： | 1 |
| 5 | Statin safety: lessons from New Drug Applications for marketed statins显示文摘 | Jacobson TA | 2006 | Am J Cardiol2006，97，8： | 1 |
| 6 | Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial显示文摘 | MORIARTY PM JACOBSON TA BRUCKERT E | 2014 | J ClinLipidol2014，8，6： | 1 |
| 7 | Toward 'pain-free' statin prescribing:clinical al- gorithm for diagnosis and management of myalgia显示文摘 | Jacobson TA | 2008 | Mayo Clin Proc2008，83，6： | 1 |
| 8 | Myopathy with statin-fibrate combination thera-py:clinical considerations显示文摘 | Jacobson TA | 2009 | Nat Rev Endocrinol2009，5，9： | 1 |
| 9 | Fatal blunt aortic injuries:a review of 242 autopsy cases显示文摘 | Burkhart HM Gomez GA Jacobson LE Pless JE Broadie TA | | 0，，： | 1 |
| 10 | Development and psychometric evaluation of the Self-efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease显示文摘 | Risser J Jacobson TA Kripalani S | 2007 | J Nurs Meas2007，15，3： | 1 |
| 11 | Statin safety: lessons from new drug applications for marketed statins显示文摘 | JACOBSON TA | 2006 | Am J Carciol2006，97，8： | 1 |
| 12 | National Lipid Association recommenda- tions for patient-centered management of dyslipidemia : part l--executive sum- mary显示文摘 | Jacobson TA Ito MK Maki KC | 2014 | J Clin Lipidol2014，8，5： | 1 |
| 13 | Role of n-3fatty acids in the treatment of hypertrig-lyceridemia and cardiovascular disease 显示文摘 | Jacobson TA | 2008 | Am J Clin Nutr2008，87，： | 1 |
| 14 | National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary 显示文摘 | Jacobson TA Ito MK Maki KC | 2014 | J Clin Lipidol2014，8，5： | 1 |
| 15 | Impact of evidence-based 'clinical judgment' on updated NHANES III data显示文摘 | Jacobson TA Griffiths GG Vasas C | | 0，，09： | 1 |
| 16 | Fibrates in combination with statins in the management of dyslipidemia显示文摘 | JACOBSON TA ZIMMERMAN FH | 2006 | J Clin Hypertens2006，8，1： | 1 |
| 17 | Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder 显示文摘 | Lipkovich I Jacobson JG Hardy TA | 2008 | BMC Psychiatry2008，8，78： | 1 |
| 18 | Fina1 conclusions and recommendations of the natioral lipid association statin safety assessment task force显示文摘 | McKenny JM Davidson MH Jacobson TA | | 0，，： | 1 |
| 19 | Progress report gastrointestinal cytoprotection byprostaglandins 显示文摘 | Jacobson ED | 1979 | Gut1979，20，1： | 1 |
| 20 | The Safety of Aggressive Statin Therapy:How Much Can Low-Density Lipo protein Cholesterol Be Lowered显示文摘 | Jacobson TA | 2006 | Mayo Clin Proc2006，81，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员